Results 131 to 140 of about 98,968 (210)

Does COMT Play a Role in Parkinson's Disease Susceptibility across Diverse Ancestral Populations?

open access: yesMovement Disorders, EarlyView.
Abstract Background The catechol‐O‐methyltransferase (COMT) gene is involved in brain catecholamine metabolism, but its association with Parkinson's disease (PD) risk remains unclear. Objective Our aim was to investigate the relationship between COMT genetic variants and PD risk across diverse ancestries.
Miguel Martín‐Bórnez   +16 more
wiley   +1 more source

Rare but Relevant? Assessing Variants in Dystonia‐Linked Genes in Parkinson's Disease

open access: yesMovement Disorders, EarlyView.
Abstract Background Dystonia and Parkinson's disease (PD) exhibit clinical and genetic overlap, but the relevance of dystonia gene variants in PD remains unclear. Objective The aim was to assess the frequency of dystonia‐linked pathogenic variants in PD.
Lara M. Lange   +37 more
wiley   +1 more source

MOESM1 of Genome-wide association study (GWAS) for morphological and yield-related traits in an oil palm hybrid (Elaeis oleifera x Elaeis guineensis) population

open access: gold, 2019
Jaime A. Osorio-Guarín   +7 more
openalex   +1 more source

Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines [PDF]

open access: bronze, 2014
Jin Yang   +11 more
openalex   +1 more source

Interactive Bioinformatics Lab: Using Genomic Databases for Active Learning in Dentistry

open access: yes
Journal of Dental Education, EarlyView.
François Isnaldo Dias Caldeira   +1 more
wiley   +1 more source

GBA1 Variants with Unknown Classification Are Modest Contributors to Parkinson's Disease Susceptibility

open access: yesMovement Disorders, EarlyView.
Abstract Background GBA1 variants cause Gaucher's disease (GD) in biallelic forms and increase Parkinson's disease (PD) risk in heterozygous carriers. Carriers of mild or severe variants (causing GD type 1 or types 2–3) can enroll in clinical trials, whereas those with GBA1 variants classified as unknown are typically excluded.
Sitki Cem Parlar   +2 more
wiley   +1 more source

Genomics and Histopathology in Interstitial Cystitis/Bladder Pain Syndrome

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Aims In April of 2025, a Global Consensus meeting on IC/BPS was held in Winston‐Salem, NC. The goal of this meeting was to establish global consensus in diagnostic criteria, phenotyping, treatment outcome assessment, and possible etiopathology in interstitial cystitis/bladder pain syndrome (IC/BPS).
Hannah Ruetten   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy